LMAT — Lemaitre Vascular Balance Sheet
0.000.00%
Last trade - 00:00
- $1.93bn
- $1.83bn
- $193.48m
- 100
- 10
- 99
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 32.7 | 27 | 70 | 82.7 | 105 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 16.6 | 19.6 | 19.6 | 22 | 25.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 92.1 | 94.3 | 140 | 162 | 195 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 30.1 | 31.1 | 32.1 | 33.5 | 39.8 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 188 | 253 | 293 | 310 | 347 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 20.9 | 25.1 | 21.8 | 25.3 | 29.9 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 40.2 | 80.2 | 38.7 | 42.3 | 48.9 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 148 | 173 | 254 | 268 | 298 |
Total Liabilities & Shareholders' Equity | 188 | 253 | 293 | 310 | 347 |
Total Common Shares Outstanding |